October 5, 2017 / 2:47 PM / 2 months ago

BRIEF-Biogen updates on new data on treatment with Spinraza

Oct 5 (Reuters) - Biogen Inc:

* Presented new data showing earlier initiation of treatment with Spinraza may improve motor function outcomes in infants with spinal muscular atrophy

* Results of new data continued to reinforce favorable efficacy and safety profile of Spinraza Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below